Osher Mini Medical School for the Public

Size: px
Start display at page:

Download "Osher Mini Medical School for the Public"

Transcription

1 Osher Mini Medical School for the Public

2

3

4 Education Research Patient care

5 Education Practice Basic science research First human studies Research Patient care Clinical studies

6

7

8

9 Lifetime risk

10 Prostate Cancer (2017) 14% 86% New cases (161,360) Deaths (26,730)

11

12

13 Benefits 5 fewer Pca deaths Harms 130 negative biopsies 120 positive biopsies 35 develop bladder, bowel or sexual side effects 8 complications of biopsy or treatment (i.e. sepsis, wound infection, DVT, MI, etc.) <1 death due to treatment Slide courtesy of Dr. Peter Carroll

14 overdiagnose overtreat

15

16

17

18 UCSF Osher Mini Medical School for the Public Westphalen AC

19 After abnormal PSA Before diagnosis, i.e. biopsy After diagnosis, i.e. biopsy Before treatment After treatment Treatment

20 After abnormal PSA Before diagnosis, i.e. biopsy MRI After diagnosis, i.e. biopsy Before treatment MRI / CT / bone scan / PET We play a role at all stages of patient care! After treatment PET Treatment CT / bone scan / PET

21

22

23 ? CT scan Ultrasound MRI

24

25 09/31/2017

26 UCSF Osher Mini Medical School for the Public Our group has over 200 publications focused on MRI of prostate cancer! Westphalen AC

27 When the MRI is negative it is unlikely the patient has a bad/aggressive prostate cancer, i.e. tumor with Gleason pattern 4

28 When the MRI is negative it is unlikely the patient has a bad/aggressive prostate cancer, i.e. tumor with Gleason pattern 4 Questions: Do men with a negative MRI need a biopsy? Do men with known cancer and negative MRI need immediate treatment?

29 Benefits 5 fewer Pca deaths Harms 130 negative biopsies 120 positive biopsies 35 develop bladder, bowel or sexual side effects 8 complications of biopsy or treatment (i.e. sepsis, wound infection, DVT, MI, etc.) <1 death due to treatment Slide courtesy of Dr. Peter Carroll

30 When the MRI is negative it is unlikely the patient has a bad/aggressive prostate cancer, i.e. tumor with Gleason pattern 4 Problem: Between 5 and 20% of Gleason 4 tumors are invisible Do invisible tumors impact patients lives? Can these tumors be followed until visible?

31 Patient A PSA B D PSA PSA PSA B TRUS guided every 3 6 months TRUS guided, per protocol at 12 to 24 months Patient B PSA PSA PSA B D B? TRUS guided TRUS guided 31

32 Patient B PSA PSA PSA B D B? TRUS guided TRUS guided Cancer is invisible? Cancer is now visible Cancer remains invisible 32

33 Flipside bad tumors are usually very positive! PI RADS scores

34 Flipside bad tumors are usually very positive! PI RADS scores Questions: Can we target these areas on biopsy to diagnose the bad cancer?

35

36 UCSF Osher Mini Medical School for the Public Westphalen AC

37 Flipside bad tumors are usually very positive! PI RADS scores Questions: Can we target only these areas?

38 Flipside bad tumors are usually very positive! PI RADS scores Questions: Can we treat only these areas?

39

40 MRI trifecta

41 Flipside bad tumors are usually very positive! PI RADS scores Problem: UCSF Variation when assigning scores Expected We is leading are planning a study rates of Gleason a study with 20 to institutions and over 2000 patients from 4 continents to determine these 4 investigate rates per score and establish not MRI guided conclusively focal quality benchmarks determined therapy

42 Biopsy Active surveillance Focal therapy We can also help patients and our physician colleagues to decide for definitive therapy (surgery or radiation)!

43

44 Normal cell PCa cell

45 Normal cell PCa cell

46 DWI AC PET ADC map T2 Slide courtesy of Dr. Thomas Hope

47 Post gad T1 Post gad T1 AC PET AC PET Slide courtesy of Dr. Thomas Hope

48 S/P RP Disease site 1: right humerus Disease site 2: left internal iliac node WB anterior MIP Slide courtesy of Dr. Thomas Hope

49 S/P RP Disease site 1: right pelvic side wall node 1 Disease site 2: right pelvic side wall node 2 WB anterior MIP Slide courtesy of Dr. Thomas Hope

50 Negative CT Negative bone scan Positive PSMA Slide courtesy of Dr. Thomas Hope

51

52 Osher Mini Medical School for the Public

PSMA PET in patients with prostate cancer

PSMA PET in patients with prostate cancer PSMA PET in patients with prostate cancer Thomas Hope, MD Assistant Professor of Radiology, UCSF Abdominal Imaging and Nuclear Medicine Co-director, PET/MRI Chief of MRI, San Francisco VA Medical Center

More information

Prostate Cancer DFP Case of the Week

Prostate Cancer DFP Case of the Week Prostate Cancer DFP Case of the Week Antonio C. Westphalen, MD PhD Clinical Prostate MR Imaging Program, Director Associate Professor of Radiology and Urology University of California, San Francisco Case

More information

Prostate Cancer MRI. Accurate Diagnosis and Treatment. PSA to Prostate MRI. for patients and curious doctors

Prostate Cancer MRI. Accurate Diagnosis and Treatment. PSA to Prostate MRI. for patients and curious doctors 6 Prostate Cancer MRI Accurate Diagnosis and Treatment PSA to Prostate MRI for patients and curious doctors Samuel Aronson, M.D. Vincent Pelsser, M.D. Franck Bladou, M.D. Armen Aprikian, M.D. & Marc Emberton,

More information

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning Temel Tirkes, M.D. Associate Professor of Radiology Director, Genitourinary Radiology Indiana University School of Medicine Department

More information

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence.

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence. Multi-parametric MR imaging in Problems: TRUS Bx Low Risk Prostate Cancer Important cancers are missed Jelle Barentsz Clinically insignificant cancers are identified by Prostate MR Center of Excellence

More information

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES

THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES THE HISTORY AND EVOLUTION OF PROSTATE CANCER DIAGNOSIS AND TREATMENT BY: DR. ANDREW GROLLMAN ALBUQUERQUE UROLOGY ASSOCIATES OVERVIEW Diagnosis Laboratory Tests PSA Free and Total PSA PCA-3 4K Score The

More information

Anatomic Imaging of Prostate Cancer

Anatomic Imaging of Prostate Cancer Masoom Haider, MD, FRCP(C) Professor of Radiology, University of Toronto Clinician Scientist, Ontario Institute of Cancer Research Senior Scientist, Sunnybrook Research Institute Chief, Dept of Medical

More information

Prostatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London

Prostatectomy as salvage therapy. Cases. Paul Cathcart - Guy s & St Thomas NHS Trust, London Prostatectomy as salvage therapy Cases Paul Cathcart - Guy s & St Thomas NHS Trust, London Attributes of brachytherapy appeal to young men who place high utility on genitourinary function At risk of

More information

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144 Objectives: Detection of prostate cancer the need for better imaging What

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 2018 Dimensions in Oncology Genitourinary Cancer Disclosures I have no financial or commercial relationships relevant to this presentation. Matthew O Shaughnessy, MD, PhD Director of Urologic Oncology

More information

Stephen McManus, MD David Levi, MD

Stephen McManus, MD David Levi, MD Stephen McManus, MD David Levi, MD Prostate MRI Indications INITIAL DETECTION, STAGING, RECURRENT TUMOR LOCALIZATION, RADIATION THERAPY PLANNING INITIAL DETECTION Clinically suspected prostate cancer before

More information

Essential Initial Activities and Clinical Outcomes

Essential Initial Activities and Clinical Outcomes Essential Initial Activities and Clinical Outcomes Crystal Farrell 1,2 & Sabrina L. Noyes 2, Joe Joslin 2, Manish Varma 2,3, Andrew Moriarity 2,3, Christopher Buchach 2,3, Leena Mammen 2,3, Brian R. Lane

More information

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

MR-US Fusion Guided Biopsy: Is it fulfilling expectations? MR-US Fusion Guided Biopsy: Is it fulfilling expectations? Kenneth L. Gage MD, PhD Assistant Member Department of Diagnostic Imaging and Interventional Radiology 4 th Annual New Frontiers in Urologic Oncology

More information

High Intensity Focused Ultrasounds for the treatment of Prostate Cancers Clinical update November D. Maruzzi - L. Ruggera

High Intensity Focused Ultrasounds for the treatment of Prostate Cancers Clinical update November D. Maruzzi - L. Ruggera High Intensity Focused Ultrasounds for the treatment of Prostate Cancers Clinical update November 2014 D. Maruzzi - L. Ruggera HIFU development Second prototype 1995-2000 Integrated Imaging 2006-2010 1993

More information

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer

Low risk. Objectives. Case-based question 1. Evidence-based utilization of imaging in prostate cancer Evidence-based utilization of imaging in prostate cancer Fergus Coakley MD, Professor of Radiology and Urology, Vice Chair for Clinical Services, Chief of Abdominal Imaging, UCSF Objectives State the modalities,

More information

If you have aggressive cancer, you would want treatment in time for a cure.

If you have aggressive cancer, you would want treatment in time for a cure. Prostate cancer: PSA screening, biopsy, new technologies The treatment/cure should never be worse than the disease. If you have aggressive cancer, you would want treatment in time for a cure. What is PSA?

More information

MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know

MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know Michael S. Cookson, MD, FACS Professor and Chair Department of Urology Director of Prostate and Urologic Oncology University

More information

Diagnosis and management of prostate cancer in the

Diagnosis and management of prostate cancer in the Diagnosis and management of prostate cancer in the Jeremy Teoh ( 張源津 ) Assistant Professor, Department of Surgery, The Chinese University of Hong Kong. Email: jeremyteoh@surgery.cuhk.edu.hk Estimated age-standardised

More information

Optimizing Implementation of Prostate MRI. Andrei S Purysko, M.D. Section of Abdominal Imaging & Nuclear Radiology Department

Optimizing Implementation of Prostate MRI. Andrei S Purysko, M.D. Section of Abdominal Imaging & Nuclear Radiology Department Optimizing Implementation of Prostate MRI Andrei S Purysko, M.D. Section of Abdominal Imaging & Nuclear Radiology Department Objectives To review the basic components of a state-of-the-art mpmri of the

More information

Patterns of care for prostate cancer An update

Patterns of care for prostate cancer An update Patterns of care for prostate cancer An update Daniel Moon Director of Robotic Surgery Epworth Healthcare Honorary Clinical Senior Lecturer University of Melbourne Consultant Urologist Peter MacCallum

More information

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director

Consensus and Controversies in Cancer of Prostate BASIS FOR FURHTER STUDIES. Luis A. Linares MD FACRO Medical Director BASIS FOR FURHTER STUDIES Main controversies In prostate Cancer: 1-Screening 2-Management Observation Surgery Standard Laparoscopic Robotic Radiation: (no discussion on Cryosurgery-RF etc.) Standard SBRT

More information

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany PET-MRI in malignant bone tumours Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to PET/MRI General considerations Bone metastases Primary bone tumours

More information

Prostate MRI: Who needs it?

Prostate MRI: Who needs it? Prostate MRI: Who needs it? Fergus Coakley MD, Professor of Radiology and Urology, Vice Chair for Clinical Services, Chief of Abdominal Imaging, UCSF Abdominal Imaging Magnetic Resonance Science Center

More information

MRI and metastases of PCa

MRI and metastases of PCa MRI and metastases of PCa François CORNUD Céline COUVIDAT David EISS Arnaud LEFEVRE IRM Paris 16, France, Paris, France Université Paris Descartes, Paris, France When imaging should be considered for detection

More information

Prostate Cancer Case Study 1. Medical Student Case-Based Learning

Prostate Cancer Case Study 1. Medical Student Case-Based Learning Prostate Cancer Case Study 1 Medical Student Case-Based Learning The Case of Mr. Powers Prostatic Nodule The effervescent Mr. Powers is found by his primary care provider to have a prostatic nodule. You

More information

A phase III trial of prostate alone vs. pelvic lymph node IMRT with or

A phase III trial of prostate alone vs. pelvic lymph node IMRT with or in partnership with A phase III trial of prostate alone vs. pelvic lymph node IMRT with or without prostate boost for intermediate and high risk localised prostate cancer Dr A Ibrahim Chief Investigator

More information

PET in Prostate Cancer

PET in Prostate Cancer PET in Prostate Cancer Tom R. Miller, M.D., Ph.D. Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis, Missouri, USA Prostate Imaging Bone Scintigraphy primarily for

More information

NIH Public Access Author Manuscript Diagn Imaging Eur. Author manuscript; available in PMC 2014 November 10.

NIH Public Access Author Manuscript Diagn Imaging Eur. Author manuscript; available in PMC 2014 November 10. NIH Public Access Author Manuscript Published in final edited form as: Diagn Imaging Eur. 2013 January ; 29(1): 12 15. PET-directed, 3D Ultrasound-guided prostate biopsy Baowei Fei, Department of Radiology

More information

D. J. Margolis 1, S. Natarajan 2, D. Kumar 3, M. Macairan 4, R. Narayanan 3, and L. Marks 4

D. J. Margolis 1, S. Natarajan 2, D. Kumar 3, M. Macairan 4, R. Narayanan 3, and L. Marks 4 Biopsy Tracking and MRI Fusion to Enhance Imaging of Cancer Within the Prostate D. J. Margolis 1, S. Natarajan 2, D. Kumar 3, M. Macairan 4, R. Narayanan 3, and L. Marks 4 1 Dept. of Radiology, UCLA, Los

More information

1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa)

1. Benign Prostate Hyperplexia (BPH) 2. Prostate Cancer (PCa) Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System. Now, we will explore two of the main problems associated

More information

Screening and Diagnosis Prostate Cancer

Screening and Diagnosis Prostate Cancer Screening and Diagnosis Prostate Cancer Daniel Heng MD MPH FRCPC Chair, Genitourinary Tumor Group Tom Baker Cancer Center University of Calgary, Canada @DrDanielHeng Outline Screening Evidence Recommendations

More information

Personalizing prostate cancer care: A clinical perspective on imaging and other biomarkers in 2017

Personalizing prostate cancer care: A clinical perspective on imaging and other biomarkers in 2017 Personalizing prostate cancer care: A clinical perspective on imaging and other biomarkers in 2017 Matthew R. Cooperberg, MD, MPH Departments of Urology and Epidemiology & Biostatistics @dr_coops Osher

More information

6th ESUR Teaching Course on Prostate MRI, Berlin 2016

6th ESUR Teaching Course on Prostate MRI, Berlin 2016 6th ESUR Teaching Course on Prostate MRI, Berlin 2016 Friday, June 10, 2016 8:00 am Registration 8:45 am Welcome Address B. Hamm and H. Thoeny 9:00 10:20 am Session 1 "ABC of the Prostate and mp- MRI:

More information

Case Discussions: Prostate Cancer

Case Discussions: Prostate Cancer Case Discussions: Prostate Cancer Andrew J. Stephenson, MD FRCSC FACS Chief, Urologic Oncology Glickman Urological and Kidney Institute Cleveland Clinic Elevated PSA 1 54 yo, healthy male, family Hx of

More information

4 th International Workshop on Diagnostic and Interventional Prostate MRI April 2019, Thursday 11 th and Friday 12 th, Paris, France

4 th International Workshop on Diagnostic and Interventional Prostate MRI April 2019, Thursday 11 th and Friday 12 th, Paris, France Organization : François Cornud, M.D., Hôpital Cochin, Department of Radiology (Pr Legmann), Course format Teaching course program of Paris Descartes University on Prostate MRI Lectures (40%) and hands-on

More information

PROSTATE CANCER SURVEILLANCE

PROSTATE CANCER SURVEILLANCE PROSTATE CANCER SURVEILLANCE ESMO Preceptorship on Prostate Cancer Singapore, 15-16 November 2017 Rosa Nadal National Cancer Institute, NIH Bethesda, USA DISCLOSURE No conflicts of interest to declare

More information

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD

Understanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD Understanding the risk of recurrence after primary treatment for prostate cancer Aditya Bagrodia, MD Aditya.bagrodia@utsouthwestern.edu 423-967-5848 Outline and objectives Prostate cancer demographics

More information

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA ESMO Cape Town 14 Feb 2018 Disclosures Advisory boards/lecturer/consultant-

More information

MR-TRUS Fusion Biopsy

MR-TRUS Fusion Biopsy MR-TRUS Fusion Biopsy Silvan Boxler Department of Urology Prostate cancer mortality according to risk groups Prevention of overdiagnosis and overtreatment Rider J, Eur Urol 2013 MR-TRUS Fusion Biopsy /

More information

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Cancer is a potentially life-threatening disease,

More information

Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality

Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality Sanoj Punnen, MD, MAS Assistant Professor of Urologic Oncology University of Miami, Miller School of Medicine and Sylvester

More information

Index Lesion Only. Prof. Phillip D Stricker

Index Lesion Only. Prof. Phillip D Stricker Index Lesion Only Prof. Phillip D Stricker Financial and Other Disclosures Off-label use of drugs, devices, or other agents: None Data from IRB-approved human research is presented I have the following

More information

Causes of Raised PSA A very large prostate Gland Infection of urine or Prostate Gland Possibility of prostate Cancer

Causes of Raised PSA A very large prostate Gland Infection of urine or Prostate Gland Possibility of prostate Cancer Causes of Raised PSA A very large prostate Gland Infection of urine or Prostate Gland Possibility of prostate Cancer Gleason score Gleason score 2-4: well differentiated (seldom reported now): Low risk

More information

Prostate MRI for local staging and surgical planning in prostate cancer

Prostate MRI for local staging and surgical planning in prostate cancer Prostate MRI for local staging and surgical planning in prostate cancer 15th Annual Floyd A. Fried Advances in Urology Symposium June 23, 2017 Ray Tan, MD, MSHPM Assistant Professor Disclosures None Objectives

More information

From the 2016 Hospitals of Regina Foundation Annual Report

From the 2016 Hospitals of Regina Foundation Annual Report From the 2016 Hospitals of Regina Foundation Annual Report 534 men received biopsies at the Prostate Assessment Centre during 2016. Two copies of PROSTATE FOR DUMMIES have been added to our library and

More information

Active Surveillance for Intermediate Risk Prostate Cancer

Active Surveillance for Intermediate Risk Prostate Cancer Active Surveillance for Intermediate Risk Prostate Cancer Eric Wallen, M.D., FACS Professor Department of Urology The University of North Carolina at Chapel Hill Disclosures: None Objectives Understand

More information

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected

More information

Prostate Cancer Local or distant recurrence?

Prostate Cancer Local or distant recurrence? Prostate Cancer Local or distant recurrence? Diagnostic flowchart Vanessa Vilas Boas Urologist VFX Hospital FEBU PSA - only recurrence PSA recurrence: 27-53% of all patients undergoing treatment with curative

More information

Prostate Case Scenario 1

Prostate Case Scenario 1 Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has

More information

Pre-test. Prostate Cancer The Good News: Prostate Cancer Screening 2012: Putting the PSA Controversy to Rest

Pre-test. Prostate Cancer The Good News: Prostate Cancer Screening 2012: Putting the PSA Controversy to Rest Pre-test Matthew R. Cooperberg, MD, MPH UCSF 40 th Annual Advances in Internal Medicine Prostate Cancer Screening 2012: Putting the PSA Controversy to Rest 1. I do not offer routine PSA screening, and

More information

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano

Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano Dipartimento di Urologia Direttore Prof. Giorgio Guazzoni Mini-Invasive Treatment in Urological Diseases Dott. Alberto Saita Responsabile Endourologia Istituto Clinico Humanitas - Rozzano alberto.saita@humanitas.it

More information

PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE

PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE PSMA PET SCANNING AND THERANOSTICS IN PROSTATE CANCER KEVIN TRACEY, MD, FRCPC PRECISION DIAGNSOTIC IMAGING REGIONAL PET/CT CENTRE DISCLOSURES/CONFLICTS NONE OBJECTIVES Understand current diagnostic role

More information

NICE BULLETIN Diagnosis & treatment of prostate cancer

NICE BULLETIN Diagnosis & treatment of prostate cancer Diagnosis & treatment of prostate cancer NICE provided the content for this booklet which is independent of any company or product advertised Diagnosis and treatment of prostate cancer Introduction In

More information

Detection, Screening and. Jelle Barentsz, Radboudumc, Nijmegen, NL

Detection, Screening and. Jelle Barentsz, Radboudumc, Nijmegen, NL Detection, Screening and Staging with mpmri Jelle Barentsz, Radboudumc, Nijmegen, NL NO CONFLICT OF INTEREST Paradigm shift Past staging TRUS-GBx ERC, MRSI invasive Current detection agressive PCa mpmri-directed

More information

Introduction. American Society of Clinical Oncology All rights reserved.

Introduction.  American Society of Clinical Oncology All rights reserved. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement This is an endorsement

More information

Navigating the Stream: Prostate Cancer and Early Detection. Ifeanyi Ani, M.D. TPMG Urology Newport News

Navigating the Stream: Prostate Cancer and Early Detection. Ifeanyi Ani, M.D. TPMG Urology Newport News Navigating the Stream: Prostate Cancer and Early Detection Ifeanyi Ani, M.D. TPMG Urology Newport News Understand epidemiology of prostate cancer Discuss PSA screening and PSA controversy Review tools

More information

Prostate Biopsy in 2017

Prostate Biopsy in 2017 Prostate Biopsy in 2017 Bob Djavan, MD, PhD Professor and Chairman, Department of Urology, Rudolfinerhaus Foundation Hospital,Vienna, Austria Director Vienna Urology foundation Board member Scientific

More information

Prostate Cancer. David Wilkinson MD Gulfshore Urology

Prostate Cancer. David Wilkinson MD Gulfshore Urology Prostate Cancer David Wilkinson MD Gulfshore Urology What is the Prostate? Male Sexual Gland Adds nutrients and fluids for sperm This fluid is added to sperm during ejaculation Urethra (urine channel)

More information

J Reinfelder, M Beck, P Goebell, P Ritt, J Sanders, T Kuwert, B Wullich, D Schmidt

J Reinfelder, M Beck, P Goebell, P Ritt, J Sanders, T Kuwert, B Wullich, D Schmidt First Experience with SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate- Specific Membrane Antigen in Patients with Biochemical Recurrence of Prostate Cancer J Reinfelder, M Beck, P Goebell, P Ritt,

More information

Interpretation of 11C choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer

Interpretation of 11C choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer Matti et al. European Journal of Hybrid Imaging (2017) 1:5 DOI 10.1186/s41824-017-0007-x European Journal of Hybrid Imaging SHORT COMMUNICATION Open Access Interpretation of 11C choline PET/CT for the

More information

Date Modified: May 29, Clinical Quality Measures for PQRS

Date Modified: May 29, Clinical Quality Measures for PQRS Date Modified: May 29, 2014 Clinical Quality s for PQRS # Domain Type Denominator Numerator Denominator Exclusions/Exceptions Rationale QCDR-1 QCDR-2 Patient Safety 102 Efficiency and Cost Reduction QCDR-3

More information

PROSTATE CANCER CONTENT CREATED BY. Learn more at

PROSTATE CANCER CONTENT CREATED BY. Learn more at PROSTATE CANCER CONTENT CREATED BY Learn more at www.health.harvard.edu TALK WITH YOUR DOCTOR Table of Contents Ask your doctor about screening and treatment options. WHAT IS PROSTATE CANCER? 4 WATCHFUL

More information

Date Modified: March 31, Clinical Quality Measures for PQRS

Date Modified: March 31, Clinical Quality Measures for PQRS Date Modified: March 31, 2015 2015 Clinical Quality s for PQRS # Domain Title Description Type Denominator Numerator Denominator Exclusions/Exceptions 1 Patient Safety Prostate Biopsy Antibiotic Process

More information

Irreversible Electroporation for the Treatment of Recurrent Prostate Cancer

Irreversible Electroporation for the Treatment of Recurrent Prostate Cancer Irreversible Electroporation for the Treatment of Recurrent Prostate Cancer after prostatectomy, radiation therapy and HiFU R. Schwartzberg, E. Günther, N. Klein, S. Zapf, R. El-Idrissi, J. Cooper, B.

More information

Pathologists Perspective on Focal Therapy: The Role of Mapping Biopsies and Markers

Pathologists Perspective on Focal Therapy: The Role of Mapping Biopsies and Markers Pathologists Perspective on Focal Therapy: The Role of Mapping Biopsies and Markers M. Scott Lucia, MD Professor and Vice Chair of Anatomic Pathology Chief of Genitourinary and Renal Pathology Dept. of

More information

Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center

Cancer 101 Spring Family Cancer Retreat 4/18/15. Amish Shah, M.D. New Mexico Cancer Center Cancer 101 Spring Family Cancer Retreat 4/18/15 Amish Shah, M.D. New Mexico Cancer Center Topics to cover What is Cancer? Screening Diagnosis/Staging Treatment Basics Clinical Trials Surveillance What

More information

The state of prostate cancer management and therapies, courtesy of Sperling Prostate Center in Florida

The state of prostate cancer management and therapies, courtesy of Sperling Prostate Center in Florida The state of prostate cancer management and therapies, courtesy of Sperling Prostate Center in Florida 1 QUALITY OF LIFE WITH AN AGING PROSTATE: THE PROTOCOL Dan Sperling, MD, DABR Medical Director The

More information

New research in prostate brachytherapy

New research in prostate brachytherapy New research in prostate brachytherapy Dr Ann Henry Associate Professor in Clinical Oncology University of Leeds and Leeds Cancer Centre PIVOTAL boost opening 2017 To evaluate - The benefits of pelvic

More information

S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet

S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet S Crouzet, O Rouvière, JY Chapelon, F Mege, X martin, A Gelet Why HIFU? Efficacy demonstrated Real time control of the target Early control of the necrosis area is possible with MRI or TRUS using contrast

More information

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging Whole Body MRI Prostate Cancer recurrence, progression and restaging Dr. Nina Tunariu Consultant Radiology Drug Development Unit and Prostate Targeted Therapies Group 12-13 Janeiro 2018 Evolving Treatment

More information

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced

More information

Radiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008

Radiation Therapy for Prostate Cancer. Resident Dept of Urology General Surgery Grand Round November 24, 2008 Radiation Therapy for Prostate Cancer Amy Hou,, MD Resident Dept of Urology General Surgery Grand Round November 24, 2008 External Beam Radiation Advances Improving Therapy Generation of linear accelerators

More information

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1 Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1

More information

Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation

Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation Active surveillance for low-risk Prostate Cancer Compared with Immediate Treatment: A Canadian cost evaluation Alice Dragomir, PhD Fabio Cury, MD Armen Aprikian, MD Introduction Clinical and economic burden

More information

Prostate Focal Therapy: What s on the Horizon? Thomas J Polascik, MD FACS

Prostate Focal Therapy: What s on the Horizon? Thomas J Polascik, MD FACS Prostate Focal Therapy: What s on the Horizon? Thomas J Polascik, MD FACS Current State of Prostate Focal Therapy Patient Selection Focal Ablation Technology and Technique Follow-up/ Surveillance after

More information

Alberto Briganti, M.D., PhD

Alberto Briganti, M.D., PhD Alberto Briganti, M.D., PhD Professore Orinario di Urologia IRCCS San Raffaele Divisione di Oncologia / Unità di Urologia Urological Research Institute (URI) Università Vita-Salute San Raffaele, Milano

More information

Radioligand imaging & treatment of prostate cancer

Radioligand imaging & treatment of prostate cancer Radioligand imaging & treatment of prostate cancer Christiaan Schiepers, MD, PhD University of California Los Angeles CANM-CAMRT JOINT ANNUAL CONFERENCE MARCH 22-24, 2018 VANCOUVER, B.C. I do not have

More information

The role of PSA in detection and management of prostate cancer

The role of PSA in detection and management of prostate cancer The role of PSA in detection and management of prostate cancer Kirby R. The role of PSA in detection and management of prostate cancer. Practitioner 2016; 260(1792):17-21 Professor Roger Kirby MA MD FRCS

More information

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases. Case Scenario 1 3/8/13 H&P 68 YR W/M presents w/elevated PSA. Patient is a non-smoker, current alcohol use. Physical Exam: On digital rectal exam the sphincter tone is normal and there is a 1 cm nodule

More information

Utility of Prostate MRI. John R. Leyendecker, MD

Utility of Prostate MRI. John R. Leyendecker, MD Utility of Prostate MRI John R. Leyendecker, MD Professor of Radiology and Urology Executive Vice Chair of Clinical Operations Section Head, Abdominal Imaging Wake Forest University School of Medicine;

More information

GUIDELINEs ON PROSTATE CANCER

GUIDELINEs ON PROSTATE CANCER GUIDELINEs ON PROSTATE CANCER (Text update March 2005: an update is foreseen for publication in 2010. Readers are kindly advised to consult the 2009 full text print of the PCa guidelines for the most recent

More information

Targeting and Treating Cancer

Targeting and Treating Cancer Targeting and Treating Cancer Mark R. Baker, Chief Executive Officer Jefferies Healthcare Conference June 2015 Disclosure Notice This presentation may contain projections and other forward-looking statements

More information

Introduction. Growths in the prostate can be benign (not cancer) or malignant (cancer).

Introduction. Growths in the prostate can be benign (not cancer) or malignant (cancer). This information was taken from urologyhealth.org. Feel free to explore their website to learn more. Another trusted website with good information is the national comprehensive cancer network (nccn.org).

More information

Attachment #2 Overview of Follow-up

Attachment #2 Overview of Follow-up Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer

More information

X, Y and Z of Prostate Cancer

X, Y and Z of Prostate Cancer X, Y and Z of Prostate Cancer Dr Tony Michele Medical Oncologist Prostate cancer Epidemiology Current EUA (et al) guidelines on Advanced Prostate Cancer Current clinical management in specific scenarios

More information

NCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer Webinar #5: NCRA /9/17 Eileen Tonner, MS

NCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer Webinar #5: NCRA /9/17 Eileen Tonner, MS NCDB Special Study: Post-Active Treatment Surveillance in Prostate Cancer Webinar #5: NCRA 2017-044 5/9/17 Eileen Tonner, MS Purpose of the Study For patients who have received curative-intent prostate

More information

Prostate Overview Quiz

Prostate Overview Quiz Prostate Overview Quiz 1. The path report reads: Gleason 3 + 4 = 7. The Gleason s score is a. 3 b. 4 c. 7 d. None of the above 2. The path report reads: Moderately differentiated adenocarcinoma of the

More information

Cancer Screening 2009: New Tests, New Choices

Cancer Screening 2009: New Tests, New Choices Objectives Cancer Screening 2009: New Tests, New Choices UCSF Annual Review in Family Medicine April 21, 2009 Michael B. Potter, MD Professor, Clinical Family and Community Medicine UCSF School of Medicine

More information

Prostate cancer timed clinical pathways

Prostate cancer timed clinical pathways Prostate cancer timed clinical pathways December 2017 1 Context This document sets out preliminary best practice timed clinical pathways for prostate cancer. It is anticipated that Cancer Alliances will

More information

1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct margin.

1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct margin. Figure 3 PI-RADS assessment for peripheral zone on T2-weighted imaging. 1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct

More information

Managing Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps?

Managing Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps? Managing Prostate Cancer After Initital Treatment Fails: Are There Good Next Steps? Michael J Zelefsky, M.D. Professor of Radiation Oncology Chief Brachytherapy Service Department of Radiation Oncology

More information

Novel Imaging in Advanced Prostate Cancer

Novel Imaging in Advanced Prostate Cancer Novel Imaging in Advanced Prostate Cancer Robert J. Hamilton, MD MPH FRCSC Princess Margaret Cancer Centre ICUC Saturday January 21, 2017 Company/Organizati Details Faculty/Presenter on Disclosures I am

More information

Department of Urology, Cochin hospital Paris Descartes University

Department of Urology, Cochin hospital Paris Descartes University Technical advances in the treatment of localized prostate cancer Pr Michaël Peyromaure Department of Urology, Cochin hospital Paris Descartes University Introduction Curative treatments of localized prostate

More information

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for

Patient Information. Prostate Tissue Ablation. High Intensity Focused Ultrasound for High Intensity Focused Ultrasound for Prostate Tissue Ablation Patient Information CAUTION: Federal law restricts this device to sell by or on the order of a physician CONTENT Introduction... 3 The prostate...

More information

Prostate Cancer Treatment Experts

Prostate Cancer Treatment Experts Prostate Cancer Treatment Experts Category Offering HIFU A Cutting-Edge, Non-Invasive Treatment with Low Risk of Side Effects While prostate cancer is a fairly common disease among men in the US, with

More information

10/30/2018. Martha K. Terris, MD Witherington Distinguished Professor and Chair Medical College of Georgia Urology November 5, 2018

10/30/2018. Martha K. Terris, MD Witherington Distinguished Professor and Chair Medical College of Georgia Urology November 5, 2018 Martha K. Terris, MD Witherington Distinguished Professor and Chair Medical College of Georgia Urology November 5, 2018 Elevated PSA and/or nodule on digital rectal examination Prostate biopsies If initial

More information

Does Imaging of Advanced PC change a suggested treatment?

Does Imaging of Advanced PC change a suggested treatment? Does Imaging of Advanced PC change a suggested treatment? Professor Bertrand Tombal, MD, PhD Cliniques universitaires Saint-Luc Université catholique de Louvain Brussels, Belgium Credentials and conflict

More information

How do I control (monitor) patients receiving TRT after prostate cancer treatment

How do I control (monitor) patients receiving TRT after prostate cancer treatment How do I control (monitor) patients receiving TRT after prostate cancer treatment Anthony J. Bella MD, FRCSC Greta and John Hansen Chair in Men s Health Research Division of Urology, Department of Surgery

More information

Best Papers. F. Fusco

Best Papers. F. Fusco Best Papers UROLOGY F. Fusco Best papers - 2015 RP/RT Oncological outcomes RP/RT IN ct3 Utilization trends RP/RT Complications Evolving role of elnd /Salvage LND This cohort reflects the current clinical

More information

Tissue characterisation, Cancer, Quality assurance /ecr2015/B-0553

Tissue characterisation, Cancer, Quality assurance /ecr2015/B-0553 Role of DWI at prostatic lesions at 3T-MRI in the discrimination of grading: correlation of imaging, quantitative analysis and pathology at 189 MR-guided prostate biopsies Poster No.: B-0553 Congress:

More information